Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

BACKGROUND: Sentinel lymph node biopsy (SNB) still remains a key procedure to appropriately stage melanoma patients and to select those who are candidate to novel treatments with immunotherapy and targeted therapy in the adjuvant setting. The impact of timing of SNB on disease-free survival (DFS) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandalà, Mario, Galli, Francesca, Patuzzo, Roberto, Maurichi, Andrea, Mocellin, Simone, Rossi, Carlo R., Rulli, Eliana, Montesco, Maria, Quaglino, Pietro, Caliendo, Virginia, De Giorgi, Vincenzo, Merelli, Barbara, Caracò, Corrado, Piazzalunga, Dario, Labianca, Alice, Ribero, Simone, Senetta, Rebecca, Gianatti, Andrea, Valeri, Barbara, Massi, Daniela, Ascierto, Paolo A., Santinami, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391020/
https://www.ncbi.nlm.nih.gov/pubmed/32739767
http://dx.doi.org/10.1016/j.ejca.2020.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391020/
https://www.ncbi.nlm.nih.gov/pubmed/32739767
http://dx.doi.org/10.1016/j.ejca.2020.07.001

Ejemplares similares